1. Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn’s Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells
    Dominika Kovács et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  2. Paris polyphylla extract attenuates colitis in mice by regulating PPAR-γ mediated Treg/Th17 balance
    Long He et al, 2023, Journal of Ethnopharmacology CrossRef
  3. Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation
    Flurina Böhi et al, 2024, Biomedicines CrossRef
  4. CD38: An important regulator of T cell function
    Wentao Li et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  5. Stanniocalcin‐1 Promotes PARP1‐Dependent Cell Death via JNK Activation in Colitis
    Liguo Zhu et al, 2024, Advanced Science CrossRef
  6. 3-aminobenzamide protects against colitis associated diabetes mellitus in male BALB/c mice: Role of PARP-1, NLRP3, SIRT-1, AMPK
    Shivani Singla et al, 2023, Biochimie CrossRef
  7. Identification of SUMOylation-related signature genes associated with immune infiltration in ulcerative colitis through bioinformatics analysis and experimental validation
    Ying Long et al, 2025, Gene CrossRef
  8. Traditional Chinese Medicine formulas-based interventions on colorectal carcinoma prevention: The efficacies, mechanisms and advantages
    Xiaojuan Tang et al, 2025, Journal of Ethnopharmacology CrossRef
  9. Quantitative Determination of 5-Aminoisoquinoline, a PARP-1 Inhibitor by UPLC-MS/MS: In Silico ADME Profile and In Vitro Metabolic Stability Study
    Muzaffar Iqbal et al, 2022, Applied Sciences CrossRef
  10. Ibuprofen modulates macrophage polarization by downregulating poly (ADP-ribose) polymerase 1
    Pei-Hua Wang et al, 2024, International Immunopharmacology CrossRef
  11. Epithelial NAD+ depletion drives mitochondrial dysfunction and contributes to intestinal inflammation
    Elizabeth A. Novak et al, 2023, Frontiers in Immunology CrossRef
  12. Research progress of phenolic compounds regulating IL‐6 to exert antitumor effects
    Tingting Xia et al, 2021, Phytotherapy Research CrossRef
  13. Shaoyao decoction alleviates TNBS-induced ulcerative colitis by decreasing inflammation and balancing the homeostasis of Th17/Treg cells
    Dongsheng Wu et al, 2023, BMC Complementary Medicine and Therapies CrossRef